UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000063541 |
|---|---|
| Receipt number | R000072644 |
| Scientific Title | Observational study of energy metabolism-related measures using PET imaging (SIC-2026-07-ENERGY) |
| Date of disclosure of the study information | 2026/11/09 |
| Last modified on | 2026/10/30 10:04:51 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Observational study of energy metabolism-related measures using PET imaging (SIC-2026-07-ENERGY)
Acronym
Observational study of energy metabolism-related measures
Scientific Title
Observational study of energy metabolism-related measures using PET imaging (SIC-2026-07-ENERGY)
Scientific Title:Acronym
Observational study of energy metabolism-related measures
Region
| Japan |
Condition
Condition
Not applicable
Classification by specialty
| Not applicable | Adult |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To investigate the relationships among various metabolic indicators.
Basic objectives2
Others
Basic objectives -Others
To investigate the relationships among various metabolic indicators.
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
PET imaging values and biological markers
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 50 | years-old | > |
Gender
Male and Female
Key inclusion criteria
(1) Adults aged 20 to less than 50 years at informed consent.
(2) Individuals able to attend the study site on designated dates.
(3) Individuals who understand the study and provide written informed consent.
Key exclusion criteria
(1) Subjects whose systolic pressure <90 mmHg.
(2) Subjects in pregnancy or lactation
(3) Subjects who are participating in other clinical studies, or who finished clinical study within 4 weeks.
(4) Subjects who are applicable to following items
a) Subjects with disease on heart, liver, kidney or other organs complication.
b) Subjects with a previous history of disease on circulatory organs.
c) Subjects who are contracting diabetes.
d) Subjects with a history of cancer, tuberculosis, or other serious illness
(5) Subjects who have an unsteady lifestyle because of a working shift or a night shift.
(6) Smoker.
(7) Subjects who drink a lot.
(8) Subjects whose BMI is less the 18.5 or over 25.0
(9) Subjects who are judged as unsuitable for the study by the principal investigator for other reasons.
Target sample size
120
Research contact person
Name of lead principal investigator
| 1st name | Toshihide |
| Middle name | |
| Last name | Suzuki |
Organization
Suntory Global Innovation Center Ltd.
Division name
Research Institute
Zip code
619-0284
Address
8-1-1 Seikadai, Seika-cho, Soraku-gun, Kyoto, Japan
TEL
050-1804-0232
Toshihide_Suzuki@suntory.co.jp
Public contact
Name of contact person
| 1st name | Natsumi |
| Middle name | |
| Last name | Hiraki |
Organization
Suntory Global Innovation Center Ltd.
Division name
Research Institute
Zip code
619-0284
Address
8-1-1 Seikadai, Seika-cho, Soraku-gun, Kyoto, Japan
TEL
05018040208
Homepage URL
Natsumi_Hiraki@suntory.co.jp
Sponsor or person
Institute
Other
Institute
Department
Personal name
Funding Source
Organization
None
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Medical Corporation Jikokai Fukuzumi Internal Medicine Clinic Clinical Trial Review Committee
Address
1-2-5 Fukuzumi-2 jo, Toyohira-ku, Sapporo-shi, Hokkaido.
Tel
011-836-3531
shibata@jkkai.or.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2026 | Year | 11 | Month | 09 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Preinitiation
Date of protocol fixation
| 2026 | Year | 11 | Month | 02 | Day |
Date of IRB
Anticipated trial start date
| 2026 | Year | 11 | Month | 10 | Day |
Last follow-up date
| 2027 | Year | 03 | Month | 05 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
To investigate the relationships among various metabolic indicators.
Management information
Registered date
| 2026 | Year | 11 | Month | 06 | Day |
Last modified on
| 2026 | Year | 10 | Month | 30 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072644
